KRUNG THAI BANK PUBLIC CO LTDKRUNG THAI BANK PUBLIC CO LTDKRUNG THAI BANK PUBLIC CO LTD

KRUNG THAI BANK PUBLIC CO LTD

No trades
See on Supercharts

Key facts today


Novo Nordisk's shares fell 7.7% after President Trump's executive order to cut prescription drug prices by 30% to 80%, raising concerns over revenue from its key GLP-1 drugs.
Novo Nordisk announced positive Phase 3 results for Sogroya® (somapacitan), a weekly growth hormone for children, outperforming daily treatments in late-stage trials for growth disorders.
Novo Nordisk's weight-loss drug Wegovy is central to talks on the most-favored nation policy, which seeks to lower Medicare drug prices, possibly affecting the company's U.S. pricing strategy.
Analyze the impactAnalyze the impact
Market capitalization
‪9.80 T‬THB
115.68THB
‪480.63 B‬THB
‪1.38 T‬THB
‪3.16 B‬
Beta (1Y)
0.10

About NOVO NORDISK B A/S


CEO
Lars Fruergaard Jørgensen
Headquarters
Bagsværd
Founded
1931
ISIN
TH0150122503
FIGI
BBG01Q6L1RY0
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
N
XS282046075
NOVO NO.F.NL 24/34 MTN
Yield to maturity
3.39%
Maturity date
May 21, 2034
N
XS282045567
NOVO NO.F.NL 24/31 MTN
Yield to maturity
2.97%
Maturity date
Jan 21, 2031
XS244124704
NOVO NO.F.NL 22/30MTN
Yield to maturity
2.81%
Maturity date
Mar 31, 2030
N
XS282045460
NOVO NO.F.NL 24/29 MTN
Yield to maturity
2.66%
Maturity date
Jan 21, 2029
XS234803042
NOVO NO.F.NL 21/28
Yield to maturity
2.57%
Maturity date
Jun 4, 2028
XS244933017
NOVO NO.F.NL 22/27MTN
Yield to maturity
2.47%
Maturity date
Sep 30, 2027
N
XS282044994
NOVO NO.F.NL 24/26 MTN
Yield to maturity
2.44%
Maturity date
May 21, 2026

See all NOVOB80 bonds 


Check out other big names from the same industry as NOVOB80.